REGENXBIO Inc. et al v. Sarepta Therapeutics, Inc., et al. > Documents
Date Field | Doc. No. | Description (Pages) |
---|---|---|
Jan 12, 2024 | 239 | Notice of Appeal* (1) |
Oct 9, 2023 | 213 | REDACTED VERSION of 207 Answering Brief in Opposition,, by Sarepta Therapeutics Three, LLC, Sarepta Therapeutics, Inc.. (Fahnestock, Derek) (Entered: 10/09/2023) (30) |
Oct 9, 2023 | 214 | REDACTED VERSION of 208 Declaration by Sarepta Therapeutics Three, LLC, Sarepta Therapeutics, Inc.. (Attachments: # 1 Exhibits 1-13)(Fahnestock, Derek) (Entered: 10/09/2023) (0) |
Oct 9, 2023 | 215 | REDACTED VERSION of 209 Answering Brief in Opposition, by REGENXBIO Inc., The Trustees of the University of Pennsylvania. (Morrison, Susan) (Entered: 10/09/2023) (30) |
Oct 9, 2023 | 216 | REDACTED VERSION of 210 Declaration of Susan E. Morrison, by REGENXBIO Inc., The Trustees of the University of Pennsylvania. (Attachments: # 1 Exhibit 28, # 2 Exhibit 29, # 3 Exhibit 30, # 4 Exhibit 31, # 5 Exhibit 32, # 6 Exhibit 33, # 7 Exhibit 34, # 8 Exhibit 35, # 9 Exhibit 36, # 10 Exhibit 37, # 11 Exhibit 38, # 12 Exhibit 39)(Morrison, Susan) Modified on 10/10/2023 (nms). (Entered: 10/09/2023) (0) |
Oct 4, 2023 | 212 | NOTICE requesting Clerk to remove Eric Kraeutler as co-counsel. Reason for request: Retirement from Morgan, Lewis & Bockius LLP. (Dudash, Amy) (Entered: 10/04/2023) (2) |
Sep 29, 2023 | 211 | STIPULATION and Order - filed by REGENXBIO Inc.. (Kraning, Casey) Modified on 9/29/2023 (lah). (Entered: 09/29/2023) (2) |
Sep 25, 2023 | 207 | [SEALED] ANSWERING BRIEF in Opposition re 194 MOTION for Summary Judgment that Sarepta's Infringing Activities are Not Protected by the Save Harbor of 35 U.S.C. Section 271(E)1), 193 MOTION for Summary Judgment of No Invalidity Under 35 U.S.C. Section 101, 196 MOTION to Preclude the Testimony of Carla Mulhern on Hold-up, and 195 MOTION to Preclude the Testimony of Dr. Mark Kay on Invalidity Under 35 U.S.C. Section 112, filed by Sarepta Therapeutics Three, LLC, Sarepta Therapeutics, Inc..Reply Brief due date per Local Rules is 10/2/2023. (Fahnestock, Derek) Modified on 9/25/2023 (nms). (Entered: 09/25/2023) (0) |
Sep 25, 2023 | 208 | [SEALED] DECLARATION of Anastasia M. Fernands re 207 Answering Brief in Opposition, by Sarepta Therapeutics Three, LLC, Sarepta Therapeutics, Inc.. (Attachments: # 1 Exhibits 1-13)(Fahnestock, Derek) Modified on 9/25/2023 (nms). (Entered: 09/25/2023) (0) |
Sep 25, 2023 | 209 | [SEALED] ANSWERING BRIEF in Opposition re 190 MOTION for Summary Judgment and to Exclude Expert Opinions, filed by REGENXBIO Inc., The Trustees of the University of Pennsylvania. Reply Brief due date per Local Rules is 10/2/2023. (Morrison, Susan) Modified on 9/25/2023 (nms). (Entered: 09/25/2023) (0) |
Sep 25, 2023 | 210 | [SEALED] DECLARATION of Susan E. Morrison re 209 Answering Brief in Opposition, by REGENXBIO Inc., The Trustees of the University of Pennsylvania. (Attachments: # 1 Exhibit 28, # 2 Exhibit 29, # 3 Exhibit 30, # 4 Exhibit 31, # 5 Exhibit 32, # 6 Exhibit 33, # 7 Exhibit 34, # 8 Exhibit 35, # 9 Exhibit 36, # 10 Exhibit 37, # 11 Exhibit 38, # 12 Exhibit 39)(Morrison, Susan) Modified on 9/25/2023 (nms). (Entered: 09/25/2023) (0) |
Sep 5, 2023 | 204 | REDACTED VERSION of 191 Opening Brief in Support, by Sarepta Therapeutics Three, LLC, Sarepta Therapeutics, Inc.. (Fahnestock, Derek) (Entered: 09/05/2023) (30) |
Sep 5, 2023 | 205 | REDACTED VERSION of 192 Declaration of Molly K. Moore, Volume 1 of 2 , by Sarepta Therapeutics Three, LLC, Sarepta Therapeutics, Inc.. (Attachments: # 1 Exhibits 1-12)(Fahnestock, Derek) Modified on 9/5/2023 (nms). (Entered: 09/05/2023) (0) |
Sep 5, 2023 | 206 | REDACTED VERSION of 198 Declaration of Molly K. Moore, Volume 2 of 2, by Sarepta Therapeutics Three, LLC, Sarepta Therapeutics, Inc.. (Attachments: # 1 Exhibits 13-14, # 2 Exhibits 15-19, # 3 Exhibit 20, part 1, # 4 Exhibit 20, part 2, # 5 Exhibits 21-27)(Fahnestock, Derek) Modified on 9/6/2023 (nms). (Entered: 09/05/2023) (0) |
Sep 1, 2023 | 201 | STIPULATION and Order to extend time to submit redacted versions of D.I. 191, 192, and 198 to September 5, 2023 - filed by Sarepta Therapeutics Three, LLC, Sarepta Therapeutics, Inc.. (Fahnestock, Derek) Modified on 9/1/2023 (nms). (Entered: 09/01/2023) (2) |
Sep 1, 2023 | 202 | REDACTED VERSION of 197 Opening Brief in Support,, by REGENXBIO Inc.. (Morrison, Susan) (Entered: 09/01/2023) (30) |
Sep 1, 2023 | 203 | REDACTED VERSION of 200 Declaration of Susan E. Morrison, by REGENXBIO Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21, # 22 Exhibit 22, # 23 Exhibit 23, # 24 Exhibit 24, # 25 Exhibit 25, # 26 Exhibit 26, # 27 Exhibit 27)(Morrison, Susan) Modified on 9/5/2023 (nms). (Entered: 09/01/2023) (0) |
Aug 25, 2023 | 190 | MOTION for Summary Judgment and to Exclude Expert Opinions - filed by Sarepta Therapeutics Three, LLC, Sarepta Therapeutics, Inc.. (Fahnestock, Derek) Modified on 8/26/2023 (nms). (Entered: 08/25/2023) (6) |
Aug 25, 2023 | 191 | [SEALED] OPENING BRIEF in Support re 190 MOTION for Summary Judgment and to Exclude Expert Opinions, filed by Sarepta Therapeutics Three, LLC, Sarepta Therapeutics, Inc..Answering Brief/Response due date per Local Rules is 9/8/2023. (Fahnestock, Derek) Modified on 8/26/2023 (nms). (Entered: 08/25/2023) (0) |
Aug 25, 2023 | 192 | [SEALED] DECLARATION of Molly K. Moore, Volume 1 of 2 re 190 MOTION for Summary Judgment and to Exclude Expert Opinions, by Sarepta Therapeutics Three, LLC, Sarepta Therapeutics, Inc.. (Attachments: # 1 Exhibits 1-12)(Fahnestock, Derek) Modified on 8/26/2023 (nms). (Entered: 08/25/2023) (0) |
Aug 25, 2023 | 193 | MOTION for Summary Judgment of No Invalidity Under 35 U.S.C. Section 101 - filed by REGENXBIO Inc.. (Attachments: # 1 Proposed Order)(Morrison, Susan) Modified on 8/26/2023 (nms). (Entered: 08/25/2023) (0) |
Aug 25, 2023 | 194 | MOTION for Summary Judgment that Sarepta's Infringing Activities are Not Protected by the Save Harbor of 35 U.S.C. Section 271(E)1) - filed by REGENXBIO Inc.. (Attachments: # 1 Proposed Order)(Morrison, Susan) Modified on 8/26/2023 (nms). (Entered: 08/25/2023) (0) |
Aug 25, 2023 | 195 | MOTION to Preclude the Testimony of Dr. Mark Kay on Invalidity Under 35 U.S.C. Section 112 - filed by REGENXBIO Inc.. (Attachments: # 1 Proposed Order)(Morrison, Susan) Modified on 8/26/2023 (nms). (Entered: 08/25/2023) (0) |
Aug 25, 2023 | 196 | MOTION to Preclude the Testimony of Carla Mulhern on Hold-up - filed by REGENXBIO Inc.. (Attachments: # 1 Proposed Order)(Morrison, Susan) Modified on 8/26/2023 (nms). (Entered: 08/25/2023) (0) |
Aug 25, 2023 | 197 | [SEALED] OPENING BRIEF in Support re 196 MOTION to Preclude the Testimony of Carla Mulhern on Hold-up, 194 MOTION for Summary Judgment that Sarepta's Infringing Activities are Not Protected by the Save Harbor of 35 U.S.C. Section 271(E)1), 195 MOTION to Preclude the Testimony of Dr. Mark Kay on Invalidity Under 35 U.S.C. Section 112, 193 MOTION for Summary Judgment of No Invalidity Under 35 U.S.C. Section 101, filed by REGENXBIO Inc..Answering Brief/Response due date per Local Rules is 9/8/2023. (Morrison, Susan) Modified on 8/26/2023 (nms). (Entered: 08/25/2023) (0) |
Aug 25, 2023 | 198 | [SEALED] DECLARATION of Molly K. Moore, Volume 2 of re 190 MOTION for Summary Judgment, by Sarepta Therapeutics Three, LLC, Sarepta Therapeutics, Inc.. (Attachments: # 1 Exhibits 13-20, # 2 Exhibits 21-27)(Fahnestock, Derek) Modified on 8/26/2023 (nms). (Entered: 08/25/2023) (0) |
Aug 25, 2023 | 199 | 7.1.1 Statement re 190 MOTION for Summary Judgment and to Preclude Expert Opinions, by Sarepta Therapeutics Three, LLC, Sarepta Therapeutics, Inc.. (Fahnestock, Derek) Modified on 8/26/2023 (nms). (Entered: 08/25/2023) (4) |
Aug 25, 2023 | 200 | [SEALED] DECLARATION of Susan E. Morrison re 196 MOTION to Preclude the Testimony of Carla Mulher, 195 MOTION to Preclude the Testimony of Dr. Mark Kay, 193 MOTION for Summary Judgment of No Invalidity Under 35 U.S.C. Section 101, 194 MOTION for Summary Judgment that Sarepta's Infringing Activities are Not Protected by the Save Harbor of 35 U.S.C. Section 271(E)1), by REGENXBIO Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21, # 22 Exhibit 22, # 23 Exhibit 23, # 24 Exhibit 24, # 25 Exhibit 25, # 26 Exhibit 26, # 27 Exhibit 27)(Morrison, Susan) Modified on 8/26/2023 (nms). (Entered: 08/25/2023) (0) |
Jul 7, 2023 | 188 | STIPULATION to Extend Time to Complete Certain Expert Discovery specifically the deposition of Dr. Paola Leone to August 9, 2023 - filed by Sarepta Therapeutics Three, LLC, Sarepta Therapeutics, Inc.. (Fahnestock, Derek) Modified on 7/7/2023 (nms). (Entered: 07/07/2023) (2) |
Jul 7, 2023 | 189 | REDACTED VERSION of 170 Sealed Transcript. (nms) (Entered: 07/07/2023) (30) |
Jun 30, 2023 | 187 | ORAL ORDER: The Court has reviewed the papers in relation to Sareptas request to seal small portions of a court transcript. (D.I. 175 , 176 ). There are essentially three portions of the transcript at issue. On p. 4, lines 16-21 and p. 5, line 4,, I do not see how the disclosure of generally-stated information about the batches being in a warehouse would work a clearly defined and serious injury to Sarepta. I accept the need to redact p. 5, lines 8-12. Disclosure of the ballpark estimates of the other sides damages expert would not work a clearly defined and serious injury to Sarepta. Thus, for two of the three, there is no good cause to redact. Thus, the motion (D.I. 175 ) is GRANTED in part and DENIED in part. The transcript is sealed, but only the proposed redactions at p. 5, lines 8-12 are allowed. Ordered by Judge Richard G. Andrews on 6/30/2023. (nms) (Entered: 06/30/2023) (0) |
Jun 26, 2023 | 185 | NOTICE OF SERVICE of Reply Expert Report of Mark Kay, M.D., Ph.D. filed by Sarepta Therapeutics Three, LLC, Sarepta Therapeutics, Inc..(Fahnestock, Derek) (Entered: 06/26/2023) (5) |
Jun 26, 2023 | 186 | NOTICE OF SERVICE of Expert Reply Report of Michael Metzker, Expert Reply Report of Randal Heeb, and Expert Reply Report of Paola Leone filed by REGENXBIO Inc..(Kraning, Casey) (Entered: 06/26/2023) (3) |
Jun 22, 2023 | 184 | REDACTED VERSION of 181 Letter, by Sarepta Therapeutics Three, LLC, Sarepta Therapeutics, Inc.. (Attachments: # 1 Exhibits 1-2)(Fahnestock, Derek) Modified on 6/22/2023 (nms). (Entered: 06/22/2023) (0) |
Jun 20, 2023 | 182 | SO ORDERED Granting 177 STIPULATION to Extend Certain Dates (*Reset Deadlines: Dispositive Motions due by 8/25/2023). Signed by Judge Richard G. Andrews on 6/20/2023. (nms) (Entered: 06/20/2023) (2) |
Jun 20, 2023 | 183 | REDACTED VERSION of 178 Letter, by REGENXBIO Inc.. (Attachments: # 1 Text of Proposed Order, # 2 Exhibit A, # 3 Exhibit B, # 4 Exhibit C, # 5 Exhibit D, # 6 Exhibit E, # 7 Exhibit F)(Kraning, Casey) (Entered: 06/20/2023) (0) |
Jun 15, 2023 | 179 | REDACTED VERSION of 175 Unopposed Motion to Redact Transcript, by Sarepta Therapeutics Three, LLC, Sarepta Therapeutics, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Proposed Order)(Fahnestock, Derek) Modified on 6/16/2023 (nms). (Entered: 06/15/2023) (0) |
Jun 15, 2023 | 180 | REDACTED VERSION of 176 Declaration by Sarepta Therapeutics Three, LLC, Sarepta Therapeutics, Inc.. (Fahnestock, Derek) (Entered: 06/15/2023) (4) |
Jun 15, 2023 | 181 | [SEALED] Letter to The Honorable Richard G. Andrews, from Derek J. Fahnestock, regarding response to Plaintiffs' June 13, 2023 letter (D.I. 178 ). (Attachments: # 1 Exhibits 1-2)(Fahnestock, Derek) Modified on 6/16/2023 (nms). (Entered: 06/15/2023) (0) |
Jun 13, 2023 | 178 | [SEALED] Letter to The Honorable Richard G. Andrews, from Plaintiffs, regarding expert report dispute. (Attachments: # 1 Proposed Order, # 2 Exhibit A, # 3 Exhibit B, # 4 Exhibit C, # 5 Exhibit D, # 6 Exhibit E, # 7 Exhibit F) (Kraning, Casey) Modified on 6/13/2023 (nms). (Entered: 06/13/2023) (0) |
Jun 9, 2023 | 177 | STIPULATION to Extend Certain Dates - filed by REGENXBIO Inc.. (Kraning, Casey) Modified on 6/9/2023 (nms). (Entered: 06/09/2023) (2) |
Jun 8, 2023 | 175 | [SEALED] Unopposed Motion to Redact Transcript - filed by Sarepta Therapeutics Three, LLC, Sarepta Therapeutics, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Proposed Order)(Fahnestock, Derek) Modified on 6/8/2023 (nms). (Entered: 06/08/2023) (0) |
Jun 8, 2023 | 176 | [SEALED] DECLARATION of Ian M. Estepan re 175 Unopposed Motion to Redact Transcript, by Sarepta Therapeutics Three, LLC, Sarepta Therapeutics, Inc.. (Fahnestock, Derek) Modified on 6/8/2023 (nms). (Entered: 06/08/2023) (0) |
Jun 2, 2023 | 174 | ORAL ORDER: The parties have advised that a dispute has arisen requiring attention. The Court will hold a discovery conference on 6/23/2023, at 3:30 PM in Courtroom 6A. In preparation for this conference the parties shall follow the Discovery Matters and Disputes procedure as set forth in the Scheduling Order. Ordered by Judge Richard G. Andrews on 6/2/2023. (nms) (Entered: 06/02/2023) (0) |
May 30, 2023 | 172 | NOTICE OF SERVICE of (1)Rebuttal Expert Report of John Quackenbush, Ph.D., (2) Responsive Expert Report of Mark Kay, M.D., Ph.D., (3) Rebuttal Expert Report of Suzanne Sensabaugh, (4) Rebuttal Expert Report of Gabor Rubanyi, M.D., Ph.D., and (5) Rebuttal Expert Report of Carla S. Mulhern - filed by Sarepta Therapeutics Three, LLC, Sarepta Therapeutics, Inc..(Fahnestock, Derek) (Entered: 05/30/2023) (5) |
May 30, 2023 | 173 | NOTICE OF SERVICE of Expert Rebuttal Report of Michael Metzker and Expert Rebuttal Report of Paola Leone filed by REGENXBIO Inc..(Kraning, Casey) (Entered: 05/30/2023) (3) |
May 25, 2023 | 171 | Joint Notice of Intent to Request Redaction of Transcript (D.I. 170 ), by Casey Kraning. (Kraning, Casey) Modified on 5/26/2023 (nms). (Entered: 05/25/2023) (2) |
May 18, 2023 | 170 | SEALED Official Transcript of Discovery Dispute Conference held on 5/2/23 before Judge Richard G. Andrews. Court Reporter Heather M. Triozzi. (Triozzi, Heather) Modified on 6/30/2023 (nms). (Entered: 05/18/2023) (0) |
May 2, 2023 | 169 | REDACTED VERSION of 164 Letter, by Sarepta Therapeutics Three, LLC, Sarepta Therapeutics, Inc.. (Attachments: # 1 Exhibits 1-5)(Fahnestock, Derek) Modified on 5/2/2023 (nms). (Entered: 05/02/2023) (0) |
May 1, 2023 | 167 | NOTICE OF SERVICE of Opening Expert Report of Michael Metzker, Opening Expert Report of Paola Leone, and Opening Expert Report of Randal Heeb Ph.D. filed by REGENXBIO Inc..(Morrison, Susan) (Entered: 05/01/2023) (3) |
May 1, 2023 | 168 | NOTICE OF SERVICE of (1) Opening Expert Report of Mark Kay, (2) Opening Expert Report of Gabor M. Rubanyi, and (3) Opening Expert Report of John Quackenbush - filed by Sarepta Therapeutics Three, LLC, Sarepta Therapeutics, Inc..(Fahnestock, Derek) (Entered: 05/01/2023) (5) |
Apr 28, 2023 | 165 | ORAL ORDER: Defendant is requested to bring to the discovery conference on May 2, 2023, two completely unredacted copies of the disputed agreement (including schedules) and two further copies of the disputed agreement (including schedules) with the redactions that appear in the 10 K highlighted in yellow, so that the redacted and unredacted agreements can be easily compared by the Court. Ordered by Judge Richard G. Andrews on 4/28/2023. (nms) (Entered: 04/28/2023) (0) |
Apr 28, 2023 | 166 | REDACTED VERSION of 162 Letter, by REGENXBIO Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I)(Kraning, Casey) Modified on 4/28/2023 (nms). (Entered: 04/28/2023) (0) |
Apr 25, 2023 | 164 | [SEALED] Letter to The Honorable Richard G. Andrews, from Derek J. Fahnestock, regarding response to Plaintiffs April 21, 2023 Letter (D.I. 162 ). (Attachments: # 1 Exhibits 1-5)(Fahnestock, Derek) Modified on 4/25/2023 (nms). (Entered: 04/25/2023) (0) |
Apr 24, 2023 | 163 | PROPOSED Order re 162 Letter, by REGENXBIO Inc.. (Kraning, Casey) Modified on 4/24/2023 (nms). (Entered: 04/24/2023) (1) |
Apr 21, 2023 | 162 | [SEALED] Letter to The Honorable Richard G. Andrews, from Casey M. Kraning, regarding discovery dispute. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I)(Kraning, Casey) Modified on 4/21/2023 (nms). (Entered: 04/21/2023) (0) |
Apr 14, 2023 | 161 | ORAL ORDER: The parties have advised that a dispute has arisen requiring attention. The Court will hold a discovery conference on 5/2/2023, at 3:00 PM in Courtroom 6A. In preparation for this conference the parties shall follow the Discovery Matters and Disputes procedure as set forth in the Scheduling Order. Ordered by Judge Richard G. Andrews on 4/14/2023. (nms) (Entered: 04/14/2023) (0) |
Apr 7, 2023 | 158 | NOTICE OF SERVICE of Plaintiff the Trustees of the University of Pennsylvania's Objections and Responses to Defendants' Second Set of Requests for Production filed by The Trustees of the University of Pennsylvania.(Dudash, Amy) (Entered: 04/07/2023) (2) |
Apr 7, 2023 | 159 | NOTICE OF SERVICE of (1) Sarepta Therapeutics, Inc. and Sarepta Therapeutics Three, LLC's Objections and Responses to Plaintiffs Regenxbio Inc. and the Trustees of The University of Pennsylvania's First Set of Requests for Admission (Nos. 1-30), (2) Sarepta Therapeutics, Inc. and Sarepta Therapeutics Three, LLC's First Supplemental Objections and Responses to Plaintiffs Regenxbio Inc. and the Trustees of The University of Pennsylvania's Second Set of Interrogatories (Nos. 7-8), (3) Sarepta Therapeutics, Inc. and Sarepta Therapeutics Three, LLC's Third Supplemental Objections and Responses to Plaintiffs Regenxbio Inc. and the Trustees of The University of Pennsylvania's First Set of Interrogatories (Nos. 1, 3-4) and (4) Sarepta Therapeutics, Inc. and Sarepta Therapeutics Three, LLC's Objections and Responses to Plaintiffs Regenxbio Inc. and the Trustees of The University of Pennsylvania's Fifth Set of Interrogatories (Nos. 14-24) - filed by Sarepta Therapeutics Three, LLC, Sarepta Therapeutics, Inc..(Fahnestock, Derek) (Entered: 04/07/2023) (5) |
Apr 7, 2023 | 160 | NOTICE OF SERVICE of (1) Plaintiffs' Third Supplemental Objections and Responses to Defendants' First Set of Interrogatories (Nos. 1-16) (Supplementing ROGS. 1, 4, 6-16); (2) Plaintiffs' Objections and Responses to Defendants' Second Set of Interrogatories (Nos. 17-25); (3) Plaintiff REGENXBIO Inc.'s Objections and Responses to Defendants' Second Set of Requests for Production of Documents and Things (Nos. 103-109); and (4) Plaintiffs' Objections and Responses to Defendants' First Set of Requests for Admission (Nos. 1-30) filed by REGENXBIO Inc..(Kraning, Casey) (Entered: 04/07/2023) (3) |
Mar 31, 2023 | 157 | NOTICE OF SERVICE of Sarepta Therapeutics, Inc. and Sarepta Therapeutics Three, LLC's Second Amended Initial Disclosures Pursuant to Fed. R. Civ. P. 26(a)(1) and Paragraph 3 of the Default Standard for Discovery - filed by Sarepta Therapeutics Three, LLC, Sarepta Therapeutics, Inc..(Fahnestock, Derek) (Entered: 03/31/2023) (5) |
Mar 29, 2023 | 155 | STIPULATION to Extend Time to Complete Certain Fact Discovery - by Sarepta Therapeutics Three, LLC, Sarepta Therapeutics, Inc.. (Fahnestock, Derek) (Entered: 03/29/2023) (3) |
Mar 29, 2023 | 156 | SO ORDERED, re 155 Stipulation to Extend Time to Complete Certain Fact Discovery. Signed by Judge Richard G. Andrews on 3/29/2023. (nms) (Entered: 03/29/2023) (3) |
Mar 22, 2023 | 154 | MOTION for Pro Hac Vice Appearance of Attorney Molly Moore - filed by Sarepta Therapeutics Three, LLC, Sarepta Therapeutics, Inc.. (Fahnestock, Derek) (Entered: 03/22/2023) (5) |
Mar 16, 2023 | 153 | NOTICE to Take Deposition of John S. Swartley on March 27, 2023 filed by Sarepta Therapeutics Three, LLC, Sarepta Therapeutics, Inc..(Fahnestock, Derek) (Entered: 03/16/2023) (4) |
Mar 14, 2023 | 152 | NOTICE OF SERVICE of Plaintiffs' Second Supplemental Objections and Responses to Defendants' First Set of Interrogatories (No. 7) filed by REGENXBIO Inc..(Kraning, Casey) (Entered: 03/14/2023) (2) |
Mar 9, 2023 | 151 | NOTICE to Take Deposition of Mark Murphy on March 17, 2023 filed by Sarepta Therapeutics Three, LLC, Sarepta Therapeutics, Inc..(Fahnestock, Derek) (Entered: 03/09/2023) (4) |
Mar 1, 2023 | 148 | NOTICE OF SERVICE of Plaintiff The Trustees of the University of Pennsylvania's Responses and Objections to Defendants' Notice of Deposition Pursuant to Fed. R. Civ. P. 30(b)(6) filed by The Trustees of the University of Pennsylvania.(Dudash, Amy) (Entered: 03/01/2023) (2) |
Mar 1, 2023 | 149 | NOTICE OF SERVICE of (1) Defendants' Second Set of Requests for Production to Plaintiff REGENXBIO Inc. (Nos. 103 - 109), (2) Defendants' Second Set of Requests for Production to Plaintiff the Trustees of the University of Pennsylvania (Nos. 103 - 111), (3) Sarepta Therapeutics, Inc.'s Second Set of Interrogatories to Plaintiffs. (Nos. 17-25) and (4) Sarepta Therapeutics, Inc. and Sarepta Therapeutics Three, LLC's First Set of Requests for Admission to Plaintiffs REGENXBIO Inc. and the Trustees of the University of Pennsylvanias (Nos. 1-30) - filed by Sarepta Therapeutics Three, LLC, Sarepta Therapeutics, Inc..(Fahnestock, Derek) (Entered: 03/01/2023) (6) |
Mar 1, 2023 | 150 | NOTICE OF SERVICE of Plaintiffs REGENXBIO, Inc. and The Trustees of The University of Pennsylvania's Fifth Set of Interrogatories to Defendants Sarepta Therapeutics, Inc. and Sarepta Therapeutics Three, LLC (Nos. 14-24) and Plaintiffs REGENXBIO, Inc. and The Trustees of The University of Pennsylvania's First Set of Requests for Admission to Defendants Sarepta Therapeutics, Inc. and Sarepta Therapeutics Three, LLC (Nos. 1-30) filed by REGENXBIO Inc..(Morrison, Susan) (Entered: 03/01/2023) (3) |
Feb 24, 2023 | 147 | NOTICE OF SERVICE of Defendants' Objections and Responses to Plaintiff REGENXBIO Inc.'s Notice of Rule 30(b)(6) Deposition of Sarepta Therapeutics, Inc. and Sarepta Therapeutics Three, LLC - filed by Sarepta Therapeutics Three, LLC, Sarepta Therapeutics, Inc..(Fahnestock, Derek) (Entered: 02/24/2023) (5) |
Feb 23, 2023 | 145 | NOTICE OF SERVICE of Subpoena to Testify at a Deposition in a Civil Action filed by REGENXBIO Inc..(Kraning, Casey) (Entered: 02/23/2023) (3) |
Feb 23, 2023 | 146 | NOTICE OF SERVICE of Plaintiff REGENXBIO Inc.'s Objections and Responses to Defendants' Notice of Deposition Pursuant to Fed. R. Civ. P. 30(b)(6) filed by REGENXBIO Inc..(Morrison, Susan) (Entered: 02/23/2023) (3) |
Feb 21, 2023 | 144 | NOTICE of Subpoena to Andrew Yost - by Sarepta Therapeutics Three, LLC, Sarepta Therapeutics, Inc. (Fahnestock, Derek) Modified on 2/21/2023 (nms). (Entered: 02/21/2023) (7) |
Feb 16, 2023 | 141 | NOTICE of Appearance by Amy Michele Dudash on behalf of The Trustees of the University of Pennsylvania (Dudash, Amy) (Entered: 02/16/2023) (1) |
Feb 16, 2023 | 142 | NOTICE of Withdrawal of Appearance of John V. Gorman by The Trustees of the University of Pennsylvania (Gorman, John) (Entered: 02/16/2023) (1) |
Feb 16, 2023 | 143 | MOTION for Pro Hac Vice Appearance of Attorney John R. Lane - filed by REGENXBIO Inc.. (Morrison, Susan) (Entered: 02/16/2023) (2) |
Feb 13, 2023 | 140 | NOTICE OF SERVICE of (1) Defendants' Notice of Fed. R. Civ. P. 30(b)(6) Deposition of Plaintiff REGENXBIO Inc. and (2) Defendants' Notice of Fed. R. Civ. P. 30(b)(6) Deposition of Plaintiff The Trustees of the University of Pennsylvania - filed by Sarepta Therapeutics Three, LLC, Sarepta Therapeutics, Inc..(Fahnestock, Derek) (Entered: 02/13/2023) (5) |
Feb 10, 2023 | 139 | NOTICE OF SERVICE of Plaintiff's Notice of 30(b)(1) Deposition of Douglas Ingram, Plaintiff's Notice of 30(b)(1) Deposition of Michael Chambers, Plaintiff's Notice of 30(b)(1) Deposition of Ian Estepan, Plaintiff's Notice of 30(b)(1) Deposition of Bilal Arif, and Notice of Rule 30(b)(6) Deposition of Sarepta Therapeutics, Inc. and Sarepta Three, LLC filed by REGENXBIO Inc..(Gupta Fiorella, Nitika) (Entered: 02/10/2023) (3) |
Feb 8, 2023 | 138 | STIPULATION to Extend Certain Dates, by REGENXBIO Inc.. (Kraning, Casey) Modified on 2/8/2023 (nms). (Entered: 02/08/2023) (2) |
Feb 1, 2023 | 137 | NOTICE OF SERVICE of Plaintiff REGENXBIO Inc.'s Amended Rule 26(a)(1) Initial Disclosures filed by REGENXBIO Inc..(Morrison, Susan) (Entered: 02/01/2023) (2) |
Jan 31, 2023 | 136 | NOTICE OF SERVICE of (1) Sarepta Therapeutics, Inc. and Sarepta Therapeutics Three, LLC's Second Supplemental Objections and Responses to Plaintiffs Regenxbio Inc. and the Trustees of the University of Pennsylvania's First Set of Interrogatories (No. 2) and (2) Sarepta Therapeutics, Inc. and Sarepta Therapeutics Three, LLC's Supplemental Objections and Responses to Plaintiffs Regenxbio Inc. and the Trustees of the University of Pennsylvania's Third Set of Interrogatories (No. 10) - filed by Sarepta Therapeutics Three, LLC, Sarepta Therapeutics, Inc..(Fahnestock, Derek) (Entered: 01/31/2023) (5) |
Jan 30, 2023 | 135 | NOTICE OF SERVICE of Sarepta Therapeutics, Inc. and Sarepta Therapeutics Three, LLC's Supplemental Initial Invalidity Contentions - filed by Sarepta Therapeutics Three, LLC, Sarepta Therapeutics, Inc..(Fahnestock, Derek) (Entered: 01/30/2023) (5) |
Jan 27, 2023 | 126 | NOTICE to Take Deposition of Mauricio R. Alvira on February 9, 2023 filed by Sarepta Therapeutics Three, LLC, Sarepta Therapeutics, Inc..(Fahnestock, Derek) (Entered: 01/27/2023) (4) |
Jan 27, 2023 | 127 | NOTICE to Take Deposition of Guangping Gao on February 16, 2023 filed by Sarepta Therapeutics Three, LLC, Sarepta Therapeutics, Inc..(Fahnestock, Derek) (Entered: 01/27/2023) (4) |
Jan 27, 2023 | 128 | NOTICE to Take Deposition of James M. Wilson on February 23, 2023 filed by Sarepta Therapeutics Three, LLC, Sarepta Therapeutics, Inc..(Fahnestock, Derek) (Entered: 01/27/2023) (4) |
Jan 27, 2023 | 129 | NOTICE to Take Deposition of Ken Mills on February 28, 2023 filed by Sarepta Therapeutics Three, LLC, Sarepta Therapeutics, Inc..(Fahnestock, Derek) (Entered: 01/27/2023) (4) |
Jan 27, 2023 | 130 | NOTICE to Take Deposition of Andrew Yost on March 2, 2023 filed by Sarepta Therapeutics Three, LLC, Sarepta Therapeutics, Inc..(Fahnestock, Derek) (Entered: 01/27/2023) (4) |
Jan 27, 2023 | 131 | NOTICE to Take Deposition of James W. Bowen on March 7, 2023 filed by Sarepta Therapeutics Three, LLC, Sarepta Therapeutics, Inc..(Fahnestock, Derek) (Entered: 01/27/2023) (4) |
Jan 27, 2023 | 132 | NOTICE to Take Deposition of Curran M. Simpson on March 8, 2023 filed by Sarepta Therapeutics Three, LLC, Sarepta Therapeutics, Inc..(Fahnestock, Derek) (Entered: 01/27/2023) (4) |
Jan 27, 2023 | 133 | NOTICE to Take Deposition of Vit Vasista on March 9, 2023 filed by Sarepta Therapeutics Three, LLC, Sarepta Therapeutics, Inc..(Fahnestock, Derek) (Entered: 01/27/2023) (4) |
Jan 27, 2023 | 134 | NOTICE to Take Deposition of Ram Palanki on March 10, 2023 filed by Sarepta Therapeutics Three, LLC, Sarepta Therapeutics, Inc..(Fahnestock, Derek) (Entered: 01/27/2023) (4) |
Jan 24, 2023 | 125 | NOTICE of Withdrawal of Appearance of Kelsey A. Bomar to Represent Plaintiff The Trustees of the University of Pennsylvania, by The Trustees of the University of Pennsylvania. (Gorman, John) Modified on 1/24/2023 (nms). (Entered: 01/24/2023) (1) |
Jan 19, 2023 | 122 | Official Transcript of Markman Hearing held on 12/20/22 before Judge Richard G. Andrews. Court Reporter Heather M. Triozzi,Email: Heather_Triozzi@ded.uscourts.gov. Transcript may be viewed at the court public terminal or order/purchased through the Court Reporter before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER. Redaction Request due 2/9/2023. Redacted Transcript Deadline set for 2/21/2023. Release of Transcript Restriction set for 4/19/2023. (Triozzi, Heather) (Entered: 01/19/2023) (66) |
Jan 19, 2023 | 123 | Official Transcript of Discovery Dispute Conference held on 01/04/23 before Judge Richard G. Andrews. Court Reporter Heather M. Triozzi,Email: Heather_Triozzi@ded.uscourts.gov. Transcript may be viewed at the court public terminal or order/purchased through the Court Reporter before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER. Redaction Request due 2/9/2023. Redacted Transcript Deadline set for 2/21/2023. Release of Transcript Restriction set for 4/19/2023. (Triozzi, Heather) (Entered: 01/19/2023) (31) |
Jan 19, 2023 | 124 | NOTICE OF SERVICE of (1) Plaintiff's Notice of Rule 30(b)(1) Deposition of Louise Rodino-Klapac; (2) Plaintiff's Notice of Rule 30(b)(1) Deposition of Patrick OMalley; (3) Plaintiff's Notice of Rule 30(b)(1) Deposition of Chris Campbell; (4) Plaintiff's Notice of Rule 30(b)(1) Deposition of Meghan Brown; (5) Plaintiff's Notice of Rule 30(b)(1) Deposition of Younghoon Oh; (6) Plaintiff's Notice of Rule 30(b)(1) Deposition of David Knisely; and (7) Plaintiff's Notice of Rule 30(b)(1) Deposition of Teji Singh filed by REGENXBIO Inc..(Morrison, Susan) (Entered: 01/19/2023) (3) |
Jan 17, 2023 | 121 | NOTICE OF SERVICE of First Amended Claim Charts Relating to Infringement filed by REGENXBIO Inc., The Trustees of the University of Pennsylvania.(Morrison, Susan) (Entered: 01/17/2023) (2) |
Jan 11, 2023 | 120 | ORDER Compelling Discovery from Defendants (see Order for further details). Signed by Judge Richard G. Andrews on 1/11/2023. (nms) (Entered: 01/11/2023) (1) |
Jan 10, 2023 | 119 | PROPOSED Order Compelling Discovery from Defendants, by REGENXBIO Inc.. (Kraning, Casey) Modified on 1/11/2023 (nms). (Entered: 01/10/2023) (1) |
Dec 30, 2022 | 118 | CLAIM CONSTRUCTION ORDER. Signed by Judge Richard G. Andrews on 12/30/2022. (nms) (Entered: 12/30/2022) (1) |
Dec 28, 2022 | 117 | REDACTED VERSION of 113 Letter, by REGENXBIO Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J)(Kraning, Casey) Modified on 12/28/2022 (nms). (Entered: 12/28/2022) (0) |
Dec 27, 2022 | 116 | Letter to The Honorable Richard G. Andrews, from Derek J. Fahnestock, in response to Plaintiff Regenxbio's December 21, 2022 letter. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2)(Fahnestock, Derek) Modified on 12/28/2022 (nms). (Entered: 12/27/2022) (0) |
Dec 23, 2022 | 115 | PROPOSED Claim Construction Order, by REGENXBIO Inc.. (Kraning, Casey) Modified on 12/23/2022 (nms). (Entered: 12/23/2022) (1) |
Dec 22, 2022 | 114 | PROPOSED Order to 113 Letter, by REGENXBIO Inc.. (Kraning, Casey) Modified on 12/22/2022 (nms). (Entered: 12/22/2022) (2) |
Dec 21, 2022 | 113 | [SEALED] Letter to Honorable Richard G. Andrews, from Casey M. Kraning, regarding discovery dispute. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J)(Kraning, Casey) Modified on 12/22/2022 (nms). (Entered: 12/21/2022) (0) |
Dec 12, 2022 | 112 | STIPULATION TO EXTEND TIME for the parties to substantially complete document production to January 17, 2023 - filed by Sarepta Therapeutics Three, LLC, Sarepta Therapeutics, Inc.. (Fahnestock, Derek) (Entered: 12/12/2022) (2) |
Dec 6, 2022 | 111 | ORAL ORDER: The parties have advised that a dispute has arisen requiring attention. The Court will hold a discovery conference on 1/4/2023, at 10:30 AM in Courtroom 6A. In preparation for this conference the parties shall follow the Discovery Matters and Disputes procedure as set forth in the Scheduling Order. Ordered by Judge Richard G. Andrews on 12/6/2022. (nms) (Entered: 12/06/2022) (0) |
Dec 1, 2022 | 109 | NOTICE OF SERVICE of Subpoena to Testify at Deposition in a Civil Action and to Produce Documents Directed to Non-Party Catalent, Inc. filed by REGENXBIO Inc..(Morrison, Susan) (Entered: 12/01/2022) (2) |
Dec 1, 2022 | 110 | REDACTED VERSION of 94 Appendix, Volume 1, by REGENXBIO Inc., The Trustees of the University of Pennsylvania. (Attachments: # 1 Exhibit A, # 2 Exhibits A.1, B and C, # 3 Declaration)(Kraning, Casey) Modified on 12/1/2022 (nms). (Entered: 12/01/2022) (0) |
Nov 30, 2022 | 108 | NOTICE to Take Deposition of Non-Party Catalent, Inc. on January 11, 2023 filed by REGENXBIO Inc..(Morrison, Susan) (Entered: 11/30/2022) (2) |
Nov 23, 2022 | 106 | ORAL ORDER: The redacted filing (D.I. 105 ) is REJECTED because parts of it are redacted in its entirety. Absent a compelling reason, supported by a statement under oath by a party, redactions in their entirety are impermissible; redactions must be done so as to redact the least possible amount of the materials submitted. Failure to make a good faith attempt at such redactions may result in sanctions, the most common of which would be simply unsealing the entire filing. Redacting in its entirety a document or parts of a document that contains publicly available materials is prima facie evidence of bad faith. A revised redacted filing is DUE within five business days. Ordered by Judge Richard G. Andrews on 11/23/2022. (nms) (Entered: 11/23/2022) (0) |
Nov 23, 2022 | 107 | REDACTED VERSION of 91 Joint Claim Construction Brief by REGENXBIO Inc., The Trustees of the University of Pennsylvania. (Morrison, Susan) (Entered: 11/23/2022) (30) |
Nov 22, 2022 | 105 | REDACTED VERSION of 94 Appendix, Volume I, by REGENXBIO Inc., The Trustees of the University of Pennsylvania. (Attachments: # 1 Exhibit A, # 2 Exhibits A.1, B and C, # 3 Declaration)(Morrison, Susan) Modified on 11/22/2022 (nms). (Entered: 11/22/2022) (0) |
Nov 17, 2022 | 93 | SO ORDERED Granting 92 Joint Motion for Claim Construction Hearing. Signed by Judge Richard G. Andrews on 11/17/2022. (nms) (Entered: 11/17/2022) (3) |
Nov 17, 2022 | 94 | [SEALED] Joint Appendix, Volume 1 re 91 Joint Claim Construction Brief, by REGENXBIO Inc., The Trustees of the University of Pennsylvania. (Attachments: # 1 Exhibit A, # 2 Exhibits A.1, B, and C , # 3 Declaration)(Morrison, Susan) Modified on 11/17/2022 (nms). Modified on 11/17/2022 (nms). (Entered: 11/17/2022) (0) |
Nov 17, 2022 | 95 | Joint Appendix, Volume 2 re 91 Joint Claim Construction Brief, by REGENXBIO Inc., The Trustees of the University of Pennsylvania. (Attachments: # 1 Declaration, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3 part 1, # 5 Exhibit 3 part 2, # 6 Exhibit 3 part 3, # 7 Exhibit 4, # 8 Exhibit 5, # 9 Exhibit 6, # 10 Exhibit 7, # 11 Exhibit 8)(Morrison, Susan) Modified on 11/17/2022 (nms). (Entered: 11/17/2022) (0) |
Nov 17, 2022 | 96 | Joint Appendix, Volume 3 re 91 Joint Claim Construction Brief, by REGENXBIO Inc., The Trustees of the University of Pennsylvania. (Attachments: # 1 Exhibit 9, # 2 Exhibit 10, # 3 Exhibit 11, # 4 Exhibit 12, # 5 Exhibit 13, # 6 Exhibit 14, # 7 Exhibit 15, # 8 Exhibit 16, # 9 Exhibit 17, # 10 Exhibit 18, # 11 Exhibit 19, # 12 Exhibit 20, # 13 Exhibit 21, # 14 Exhibit 22, # 15 Exhibit 23, # 16 Exhibit 24, # 17 Exhibit 25, # 18 Exhibit 26, # 19 Exhibit 27, # 20 Exhibit 28, # 21 Exhibit 29, # 22 Exhibit 30, # 23 Exhibit 31, # 24 Exhibit 32, # 25 Exhibit 33, # 26 Exhibit 34, # 27 Exhibit 35, # 28 Exhibit 36, # 29 Exhibit 37, # 30 Exhibit 38, # 31 Exhibit 39, # 32 Exhibit 40, # 33 Exhibit 41, # 34 Exhibit 42, # 35 Exhibit 43, # 36 Exhibit 44, # 37 Exhibit 45, # 38 Exhibit 46, # 39 Exhibit 47, # 40 Exhibit 48, # 41 Exhibit 49, # 42 Exhibit 50, # 43 Exhibit 51, # 44 Exhibit 52, # 45 Exhibit 53, # 46 Exhibit 54, # 47 Exhibit 55, # 48 Exhibit 56, # 49 Exhibit 57, # 50 Exhibit 58, # 51 Exhibit 59, # 52 Exhibit 60, # 53 Exhibit 61)(Morrison, Susan) Modified on 11/17/2022 (nms). (Entered: 11/17/2022) (0) |
Nov 17, 2022 | 97 | Joint Appendix, Volume 4 re 91 Joint Claim Construction Brief, by REGENXBIO Inc., The Trustees of the University of Pennsylvania. (Attachments: # 1 Exhibit 62, # 2 Exhibit 63, # 3 Exhibit 64, # 4 Exhibit 65, # 5 Exhibit 66, # 6 Exhibit 67, # 7 Exhibit 68, # 8 Exhibit 69, # 9 Exhibit 70, # 10 Exhibit 71, # 11 Exhibit 72, # 12 Exhibit 73, # 13 Exhibit 74, # 14 Exhibit 75, # 15 Exhibit 76, # 16 Exhibit 77, # 17 Exhibit 78, # 18 Exhibit 79, # 19 Exhibit 80, # 20 Exhibit 81, # 21 Exhibit 82, # 22 Exhibit 83, # 23 Exhibit 84, # 24 Exhibit 85, # 25 Exhibit 86, # 26 Exhibit 87, # 27 Exhibit 88)(Morrison, Susan) Modified on 11/17/2022 (nms). (Entered: 11/17/2022) (0) |
Nov 17, 2022 | 98 | Joint Appendix, Volume 5 re 91 Joint Claim Construction Brief, by REGENXBIO Inc., The Trustees of the University of Pennsylvania. (Attachments: # 1 Appendix A, # 2 Appendix B, # 3 Appendix C)(Morrison, Susan) Modified on 11/17/2022 (nms). (Entered: 11/17/2022) (0) |
Nov 17, 2022 | 99 | Joint Appendix, Volume 6 re 91 Joint Claim Construction Brief, by REGENXBIO Inc., The Trustees of the University of Pennsylvania. (Attachments: # 1 Appendix D)(Morrison, Susan) Modified on 11/17/2022 (nms). (Entered: 11/17/2022) (0) |
Nov 17, 2022 | 100 | Joint Appendix, Volume 7 re 91 Joint Claim Construction Brief, by REGENXBIO Inc., The Trustees of the University of Pennsylvania. (Attachments: # 1 Appendix E, # 2 Appendix F)(Morrison, Susan) Modified on 11/17/2022 (nms). (Entered: 11/17/2022) (0) |
Nov 17, 2022 | 101 | Joint Appendix, Volume 8 re 91 Joint Claim Construction Brief, by REGENXBIO Inc., The Trustees of the University of Pennsylvania. (Attachments: # 1 Declaration)(Morrison, Susan) Modified on 11/17/2022 (nms). (Entered: 11/17/2022) (0) |
Nov 17, 2022 | 102 | Joint Appendix, Volume 9 re 91 Joint Claim Construction Brief, by REGENXBIO Inc., The Trustees of the University of Pennsylvania. (Attachments: # 1 Declaration, # 2 Exhibits 89-90, # 3 Declaration)(Morrison, Susan) Modified on 11/17/2022 (nms). (Entered: 11/17/2022) (0) |
Nov 17, 2022 | 103 | Joint Appendix, Volume 10 re 91 Joint Claim Construction Brief, by REGENXBIO Inc., The Trustees of the University of Pennsylvania. (Attachments: # 1 Appendices A-C)(Morrison, Susan) Modified on 11/17/2022 (nms). (Entered: 11/17/2022) (0) |
Nov 17, 2022 | 104 | Joint Appendix, Volume 11 re 91 Joint Claim Construction Brief, by REGENXBIO Inc., The Trustees of the University of Pennsylvania. (Attachments: # 1 Appendix D-F)(Morrison, Susan) Modified on 11/17/2022 (nms). (Entered: 11/17/2022) (0) |
Nov 16, 2022 | 91 | [SEALED] Joint Claim Construction Brief, filed by REGENXBIO Inc., The Trustees of the University of Pennsylvania. (Morrison, Susan) Modified on 11/16/2022 (nms). (Entered: 11/16/2022) (0) |
Nov 16, 2022 | 92 | Joint Motion for Claim Construction Hearing - filed by REGENXBIO Inc., The Trustees of the University of Pennsylvania. (Morrison, Susan) Modified on 11/16/2022 (nms). (Entered: 11/16/2022) (3) |
Nov 9, 2022 | 90 | Notice of Service (5) Docket Text: NOTICE OF SERVICE of (1) Sarepta Therapeutics, Inc. and Sarepta Therapeutics Three, LLC's Objections and Responses to Plaintiffs REGENXBIO Inc. and The Trustees of the University of Pennsylvania's Third Set of Requests for Production (Nos. 87-89) and (2) Sarepta Therapeutics, Inc. and Sarepta Therapeutics Three, LLC's Objections and Responses to Plaintiffs REGENXBIO Inc. and The Trustees of the University of Pennsylvania's Fourth Set of Interrogatories (Nos. 11-13) - filed by Sarepta Therapeutics Three, LLC, Sarepta Therapeutics, Inc..(Fahnestock, Derek) |
Oct 20, 2022 | 89 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Plaintiffs' Reply Construction Brief and Leone Declaration filed by REGENXBIO Inc..(Kraning, Casey) |
Oct 11, 2022 | 88 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Plaintiffs' Third Set of Requests For Production (Nos. 87-89) and Plaintiffs' Fourth Set of Interrogatories to Defendant (Nos. 11-13) filed by REGENXBIO Inc..(Morrison, Susan) |
Oct 10, 2022 | 87 | Notice of Service (5) Docket Text: NOTICE OF SERVICE of (1) Sarepta Therapeutics, Inc. and Sarepta Therapeutics Three, LLC's Objections and Responses to Plaintiffs REGENXBIO Inc. and The Trustees of the University of Pennsylvania's Second Set of Requests for Production (Nos. 84-86) and (2) Sarepta Therapeutics, Inc. and Sarepta Therapeutics Three, LLC's Objections and Responses to Plaintiffs REGENXBIO Inc. and The Trustees of the University of Pennsylvania's Third Set of Interrogatories (Nos. 9-10) - filed by Sarepta Therapeutics Three, LLC, Sarepta Therapeutics, Inc..(Fahnestock, Derek) |
Sep 29, 2022 | 85 | Notice of Service (5) Docket Text: NOTICE OF SERVICE of (1) Defendants Sarepta Therapeutics, Inc. and Sarepta Therapeutics Three, LLC's Answering Claim Construction Brief, (2) Declaration of John Quackenbush, Ph.D. and (3) Declaration of Gabor M. Rubanyi, M.D., Ph.D. - filed by Sarepta Therapeutics Three, LLC, Sarepta Therapeutics, Inc..(Fahnestock, Derek) |
Sep 29, 2022 | 86 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Plaintiffs' Opening Claim Construction Brief filed by REGENXBIO Inc..(Morrison, Susan) |
Sep 9, 2022 | 84 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Plaintiffs' Second Set of Requests For Production and Things to Defendants (Nos. 84-86) and Plaintiffs' Third Set of Interrogatories to Defendants (Nos. 9-10) filed by REGENXBIO Inc..(Morrison, Susan) |
Aug 31, 2022 | 83 | Order (8) Docket Text: SO ORDERED Granting [82] Stipulation and Proposed Order Re: Discovery of Electronically Stored Information ("ESI"). Signed by Judge Richard G. Andrews on 8/31/2022. (nms) |
Aug 30, 2022 | 82 | Stipulation (8) Docket Text: STIPULATION and Proposed Order Re: Discovery of Electronically Stored Information ("ESI"), by REGENXBIO Inc.. (Morrison, Susan) Modified on 8/30/2022 (nms). |
Aug 23, 2022 | 81 | Notice of Service (5) Docket Text: NOTICE OF SERVICE of Sarepta Therapeutics, Inc. and Sarepta Therapeutics Three, LLC's Amended Initial Disclosures Pursuant to Fed. R. Civ. P. 26(a)(1) and Paragraph 3 of the Default Standard for Discovery - filed by Sarepta Therapeutics Three, LLC, Sarepta Therapeutics, Inc..(Fahnestock, Derek) |
Aug 19, 2022 | 79 | Claim Construction Chart (20) Docket Text: JOINT Claim Construction Chart, by REGENXBIO Inc.. (Kraning, Casey) Modified on 8/22/2022 (nms). |
Aug 19, 2022 | 80 | Appendix (Main Document) (4) Docket Text: APPENDIX to [79] Joint Claim Construction Chart, by REGENXBIO Inc.. (Attachments: # (1) Exhibit 1 part 1, # (2) Exhibit 1 part 2, # (3) Exhibit 1 part 3, # (4) Exhibit 2, # (5) Exhibit 3, # (6) Exhibit 4, # (7) Exhibit 5, # (8) Exhibit 6, # (9) Exhibit 7, # (10) Exhibit 8, # (11) Exhibit 9, # (12) Exhibit 10, # (13) Exhibit 11, # (14) Exhibit 12, # (15) Exhibit 13)(Kraning, Casey) Modified on 8/22/2022 (nms). |
Aug 19, 2022 | 80 | Appendix (Ex 1 - Part 1) (30) Docket Text: APPENDIX to [79] Joint Claim Construction Chart, by REGENXBIO Inc.. (Attachments: # (1) Exhibit 1 part 1, # (2) Exhibit 1 part 2, # (3) Exhibit 1 part 3, # (4) Exhibit 2, # (5) Exhibit 3, # (6) Exhibit 4, # (7) Exhibit 5, # (8) Exhibit 6, # (9) Exhibit 7, # (10) Exhibit 8, # (11) Exhibit 9, # (12) Exhibit 10, # (13) Exhibit 11, # (14) Exhibit 12, # (15) Exhibit 13)(Kraning, Casey) Modified on 8/22/2022 (nms). |
Aug 19, 2022 | 80 | Appendix (Ex 1 - Part 1) (30) Docket Text: APPENDIX to [79] Joint Claim Construction Chart, by REGENXBIO Inc.. (Attachments: # (1) Exhibit 1 part 1, # (2) Exhibit 1 part 2, # (3) Exhibit 1 part 3, # (4) Exhibit 2, # (5) Exhibit 3, # (6) Exhibit 4, # (7) Exhibit 5, # (8) Exhibit 6, # (9) Exhibit 7, # (10) Exhibit 8, # (11) Exhibit 9, # (12) Exhibit 10, # (13) Exhibit 11, # (14) Exhibit 12, # (15) Exhibit 13)(Kraning, Casey) Modified on 8/22/2022 (nms). |
Aug 19, 2022 | 80 | Appendix (Ex 1 - Part 3) (30) Docket Text: APPENDIX to [79] Joint Claim Construction Chart, by REGENXBIO Inc.. (Attachments: # (1) Exhibit 1 part 1, # (2) Exhibit 1 part 2, # (3) Exhibit 1 part 3, # (4) Exhibit 2, # (5) Exhibit 3, # (6) Exhibit 4, # (7) Exhibit 5, # (8) Exhibit 6, # (9) Exhibit 7, # (10) Exhibit 8, # (11) Exhibit 9, # (12) Exhibit 10, # (13) Exhibit 11, # (14) Exhibit 12, # (15) Exhibit 13)(Kraning, Casey) Modified on 8/22/2022 (nms). |
Aug 19, 2022 | 80 | Appendix (Ex 2) (30) Docket Text: APPENDIX to [79] Joint Claim Construction Chart, by REGENXBIO Inc.. (Attachments: # (1) Exhibit 1 part 1, # (2) Exhibit 1 part 2, # (3) Exhibit 1 part 3, # (4) Exhibit 2, # (5) Exhibit 3, # (6) Exhibit 4, # (7) Exhibit 5, # (8) Exhibit 6, # (9) Exhibit 7, # (10) Exhibit 8, # (11) Exhibit 9, # (12) Exhibit 10, # (13) Exhibit 11, # (14) Exhibit 12, # (15) Exhibit 13)(Kraning, Casey) Modified on 8/22/2022 (nms). |
Aug 19, 2022 | 80 | Appendix (Ex 3) (30) Docket Text: APPENDIX to [79] Joint Claim Construction Chart, by REGENXBIO Inc.. (Attachments: # (1) Exhibit 1 part 1, # (2) Exhibit 1 part 2, # (3) Exhibit 1 part 3, # (4) Exhibit 2, # (5) Exhibit 3, # (6) Exhibit 4, # (7) Exhibit 5, # (8) Exhibit 6, # (9) Exhibit 7, # (10) Exhibit 8, # (11) Exhibit 9, # (12) Exhibit 10, # (13) Exhibit 11, # (14) Exhibit 12, # (15) Exhibit 13)(Kraning, Casey) Modified on 8/22/2022 (nms). |
Aug 19, 2022 | 80 | Appendix (Ex 4) (30) Docket Text: APPENDIX to [79] Joint Claim Construction Chart, by REGENXBIO Inc.. (Attachments: # (1) Exhibit 1 part 1, # (2) Exhibit 1 part 2, # (3) Exhibit 1 part 3, # (4) Exhibit 2, # (5) Exhibit 3, # (6) Exhibit 4, # (7) Exhibit 5, # (8) Exhibit 6, # (9) Exhibit 7, # (10) Exhibit 8, # (11) Exhibit 9, # (12) Exhibit 10, # (13) Exhibit 11, # (14) Exhibit 12, # (15) Exhibit 13)(Kraning, Casey) Modified on 8/22/2022 (nms). |
Aug 19, 2022 | 80 | Appendix (Ex 5) (30) Docket Text: APPENDIX to [79] Joint Claim Construction Chart, by REGENXBIO Inc.. (Attachments: # (1) Exhibit 1 part 1, # (2) Exhibit 1 part 2, # (3) Exhibit 1 part 3, # (4) Exhibit 2, # (5) Exhibit 3, # (6) Exhibit 4, # (7) Exhibit 5, # (8) Exhibit 6, # (9) Exhibit 7, # (10) Exhibit 8, # (11) Exhibit 9, # (12) Exhibit 10, # (13) Exhibit 11, # (14) Exhibit 12, # (15) Exhibit 13)(Kraning, Casey) Modified on 8/22/2022 (nms). |
Aug 19, 2022 | 80 | Appendix (Ex 6) (30) Docket Text: APPENDIX to [79] Joint Claim Construction Chart, by REGENXBIO Inc.. (Attachments: # (1) Exhibit 1 part 1, # (2) Exhibit 1 part 2, # (3) Exhibit 1 part 3, # (4) Exhibit 2, # (5) Exhibit 3, # (6) Exhibit 4, # (7) Exhibit 5, # (8) Exhibit 6, # (9) Exhibit 7, # (10) Exhibit 8, # (11) Exhibit 9, # (12) Exhibit 10, # (13) Exhibit 11, # (14) Exhibit 12, # (15) Exhibit 13)(Kraning, Casey) Modified on 8/22/2022 (nms). |
Aug 19, 2022 | 80 | Appendix (Ex 7) (30) Docket Text: APPENDIX to [79] Joint Claim Construction Chart, by REGENXBIO Inc.. (Attachments: # (1) Exhibit 1 part 1, # (2) Exhibit 1 part 2, # (3) Exhibit 1 part 3, # (4) Exhibit 2, # (5) Exhibit 3, # (6) Exhibit 4, # (7) Exhibit 5, # (8) Exhibit 6, # (9) Exhibit 7, # (10) Exhibit 8, # (11) Exhibit 9, # (12) Exhibit 10, # (13) Exhibit 11, # (14) Exhibit 12, # (15) Exhibit 13)(Kraning, Casey) Modified on 8/22/2022 (nms). |
Aug 19, 2022 | 80 | Appendix (Ex 8) (30) Docket Text: APPENDIX to [79] Joint Claim Construction Chart, by REGENXBIO Inc.. (Attachments: # (1) Exhibit 1 part 1, # (2) Exhibit 1 part 2, # (3) Exhibit 1 part 3, # (4) Exhibit 2, # (5) Exhibit 3, # (6) Exhibit 4, # (7) Exhibit 5, # (8) Exhibit 6, # (9) Exhibit 7, # (10) Exhibit 8, # (11) Exhibit 9, # (12) Exhibit 10, # (13) Exhibit 11, # (14) Exhibit 12, # (15) Exhibit 13)(Kraning, Casey) Modified on 8/22/2022 (nms). |
Aug 19, 2022 | 80 | Appendix (Ex 9) (30) Docket Text: APPENDIX to [79] Joint Claim Construction Chart, by REGENXBIO Inc.. (Attachments: # (1) Exhibit 1 part 1, # (2) Exhibit 1 part 2, # (3) Exhibit 1 part 3, # (4) Exhibit 2, # (5) Exhibit 3, # (6) Exhibit 4, # (7) Exhibit 5, # (8) Exhibit 6, # (9) Exhibit 7, # (10) Exhibit 8, # (11) Exhibit 9, # (12) Exhibit 10, # (13) Exhibit 11, # (14) Exhibit 12, # (15) Exhibit 13)(Kraning, Casey) Modified on 8/22/2022 (nms). |
Aug 19, 2022 | 80 | Appendix (Ex 10) (30) Docket Text: APPENDIX to [79] Joint Claim Construction Chart, by REGENXBIO Inc.. (Attachments: # (1) Exhibit 1 part 1, # (2) Exhibit 1 part 2, # (3) Exhibit 1 part 3, # (4) Exhibit 2, # (5) Exhibit 3, # (6) Exhibit 4, # (7) Exhibit 5, # (8) Exhibit 6, # (9) Exhibit 7, # (10) Exhibit 8, # (11) Exhibit 9, # (12) Exhibit 10, # (13) Exhibit 11, # (14) Exhibit 12, # (15) Exhibit 13)(Kraning, Casey) Modified on 8/22/2022 (nms). |
Aug 19, 2022 | 80 | Appendix (Ex 11) (30) Docket Text: APPENDIX to [79] Joint Claim Construction Chart, by REGENXBIO Inc.. (Attachments: # (1) Exhibit 1 part 1, # (2) Exhibit 1 part 2, # (3) Exhibit 1 part 3, # (4) Exhibit 2, # (5) Exhibit 3, # (6) Exhibit 4, # (7) Exhibit 5, # (8) Exhibit 6, # (9) Exhibit 7, # (10) Exhibit 8, # (11) Exhibit 9, # (12) Exhibit 10, # (13) Exhibit 11, # (14) Exhibit 12, # (15) Exhibit 13)(Kraning, Casey) Modified on 8/22/2022 (nms). |
Aug 19, 2022 | 80 | Appendix (Ex 12) (30) Docket Text: APPENDIX to [79] Joint Claim Construction Chart, by REGENXBIO Inc.. (Attachments: # (1) Exhibit 1 part 1, # (2) Exhibit 1 part 2, # (3) Exhibit 1 part 3, # (4) Exhibit 2, # (5) Exhibit 3, # (6) Exhibit 4, # (7) Exhibit 5, # (8) Exhibit 6, # (9) Exhibit 7, # (10) Exhibit 8, # (11) Exhibit 9, # (12) Exhibit 10, # (13) Exhibit 11, # (14) Exhibit 12, # (15) Exhibit 13)(Kraning, Casey) Modified on 8/22/2022 (nms). |
Aug 19, 2022 | 80 | Appendix (Ex 13) (30) Docket Text: APPENDIX to [79] Joint Claim Construction Chart, by REGENXBIO Inc.. (Attachments: # (1) Exhibit 1 part 1, # (2) Exhibit 1 part 2, # (3) Exhibit 1 part 3, # (4) Exhibit 2, # (5) Exhibit 3, # (6) Exhibit 4, # (7) Exhibit 5, # (8) Exhibit 6, # (9) Exhibit 7, # (10) Exhibit 8, # (11) Exhibit 9, # (12) Exhibit 10, # (13) Exhibit 11, # (14) Exhibit 12, # (15) Exhibit 13)(Kraning, Casey) Modified on 8/22/2022 (nms). |
Aug 18, 2022 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [78] STIPULATION to Extend time to file Joint Claim Construction Chart to August 19, 2022. Signed by Judge Richard G. Andrews on 8/18/2022. (nms) |
Aug 17, 2022 | 77 | Notice of Appearance (2) Docket Text: NOTICE of Appearance by Casey Kraning on behalf of REGENXBIO Inc. (Kraning, Casey) |
Aug 17, 2022 | 78 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION to Extend time to file Joint Claim Construction Chart to August 19, 2022 - filed by REGENXBIO Inc.. (Morrison, Susan) Modified on 8/18/2022 (nms). |
Aug 5, 2022 | 76 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Plaintiffs' First Supplemental Objections and Responses to Defendants' First Set of Interrogatories (Nos. 1-16) filed by REGENXBIO Inc..(Morrison, Susan) |
Aug 1, 2022 | 74 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Plaintiffs' Proposed Claim Constructions filed by REGENXBIO Inc..(Morrison, Susan) |
Aug 1, 2022 | 75 | Notice of Service (5) Docket Text: NOTICE OF SERVICE of Sarepta Therapeutics, Inc. and Sarepta Therapeutics Three, LLC's Proposed Claim Constructions - filed by Sarepta Therapeutics Three, LLC, Sarepta Therapeutics, Inc..(Fahnestock, Derek) |
Jul 18, 2022 | 73 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Disclosure of Terms for Construction filed by REGENXBIO Inc., The Trustees of the University of Pennsylvania.(Morrison, Susan) |
Jul 15, 2022 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [71] STIPULATION to Extend Certain Dates. Signed by Judge Richard G. Andrews on 7/15/2022. (nms) |
Jul 15, 2022 | 71 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION to Extend Certain Dates - filed by Sarepta Therapeutics Three, LLC, Sarepta Therapeutics, Inc.. (Fahnestock, Derek) Modified on 7/15/2022 (nms). |
Jul 15, 2022 | 72 | Notice of Service (5) Docket Text: NOTICE OF SERVICE of Supplemental Objections and Responses to Plaintiffs REGENXBIO Inc. and The Trustees of the University of Pennsylvania's First Set of Interrogatories (No. 1) filed by Sarepta Therapeutics Three, LLC, Sarepta Therapeutics, Inc..(Fahnestock, Derek) |
Jul 13, 2022 | 70 | Notice of Service (5) Docket Text: NOTICE OF SERVICE of Sarepta Therapeutics, Inc. and Sarepta Therapeutics Three, LLC's Disclosure of Terms for Construction filed by Sarepta Therapeutics Three, LLC, Sarepta Therapeutics, Inc..(Fahnestock, Derek) |
Jun 16, 2022 | 69 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Plaintiff The Trustees of the University of Pennsylvania's Objections and Responses to Sarepta Therapeutics, Inc.'s First Set of Requests for Production (Nos. 1-90) filed by REGENXBIO Inc., The Trustees of the University of Pennsylvania.(Bomar, Kelsey) |
Jun 15, 2022 | 68 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Plaintiffs' Highly Confidential - Outside Counsel's Eyes Only Objections and Responses to Defendants' First Set of Interrogatories (Nos. 1-16) and Plaintiff REGENXBIO, Inc.'s Objections and Responses to Defendants' First Set of Requests for Production of Documents and Things (Nos. 1-102) filed by REGENXBIO Inc..(Morrison, Susan) |
Jun 13, 2022 | 67 | Notice of Service (5) Docket Text: NOTICE OF SERVICE of Sarepta Therapeutics, Inc. and Sarepta Therapeutics Three, LLC's Initial Invalidity Contentions - filed by Sarepta Therapeutics Three, LLC, Sarepta Therapeutics, Inc..(Fahnestock, Derek) |
May 23, 2022 | 66 | Memorandum and Order (2) Docket Text: MEMORANDUM ORDER: The Motion for Certification for Interlocutory Appeal (D.I. [40]) is DENIED. Signed by Judge Richard G. Andrews on 5/23/2022. (nms) |
May 16, 2022 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [64] MOTION for Pro Hac Vice Appearance of Attorney Anastasia M. Fernands, filed by Sarepta Therapeutics Three, LLC, Sarepta Therapeutics, Inc.. Signed by Judge Richard G. Andrews on 5/16/2022. (nms) |
May 16, 2022 | 64 | Motion for Leave to Appear Pro Hac Vice (5) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Anastasia M. Fernands - filed by Sarepta Therapeutics Three, LLC, Sarepta Therapeutics, Inc.. (Fahnestock, Derek) |
May 16, 2022 | 65 | Notice of Service (6) Docket Text: NOTICE OF SERVICE of (1) Sarepta Therapeutics, Inc.'s First Set of Requests for Production to Plaintiff The Trustees of the University of Pennsylvania (Nos. 1-90), (2) Defendants' First Set of Requests for Production to Plaintiff REGENXBIO Inc. (Nos. 1-102), (3) Sarepta Therapeutics, Inc.'s First Set of Interrogatories to Plaintiffs. (Nos. 1-16) and (4) Sarepta Therapeutics, Inc. and Sarepta Therapeutics Three, LLC's Objections and Responses to Plaintiffs REGENXBIO Inc. and The Trustees of the University of Pennsylvanias Second Set of Interrogatories (Nos. 6-8) - filed by Sarepta Therapeutics Three, LLC, Sarepta Therapeutics, Inc..(Fahnestock, Derek) |
May 13, 2022 | 63 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Plaintiffs' HC-AEO Preliminary Infringement Contentions, with Exhibit 1 Infringement Claim Charts and Appendices A-E filed by REGENXBIO Inc..(Morrison, Susan) |
Apr 27, 2022 | 62 | Notice of Service (5) Docket Text: NOTICE OF SERVICE of (1) Sarepta Therapeutics, Inc. and Sarepta Therapeutics Three, LLC's Objections and Responses to Plaintiffs Regenxbio Inc. and the Trustees of the University of Pennsylvania's First Set of Interrogatories (Nos. 1-5) and (2) Responses to Plaintiffs' First Set of Requests for Production of Documents and Things to Defendants (Nos. 1-83) - filed by Sarepta Therapeutics Three, LLC, Sarepta Therapeutics, Inc..(Fahnestock, Derek) |
Apr 21, 2022 | 61 | Order (19) Docket Text: SO ORDERED Granting [60] Proposed Protective Order. Signed by Judge Richard G. Andrews on 4/21/2022. (nms) |
Apr 20, 2022 | 60 | Proposed Order (19) Docket Text: PROPOSED Proposed Protective Order, by REGENXBIO Inc.. (Morrison, Susan) Modified on 4/20/2022 (nms). |
Apr 14, 2022 | 59 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Plaintiffs' Second Set of Interrogatories (Nos. 6-8) filed by REGENXBIO Inc..(Morrison, Susan) |
Apr 13, 2022 | 58 | Notice of Service (5) Docket Text: NOTICE OF SERVICE of Sarepta Therapeutics, Inc. and Sarepta Therapeutics Three, LLC's Core Technical Document Production [SRPT0000001 SRPT0000063] - filed by Sarepta Therapeutics Three, LLC, Sarepta Therapeutics, Inc..(Fahnestock, Derek) |
Apr 8, 2022 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [57] STIPULATION to Extend Time to submit a proposed protective order to April 20, 2022. Signed by Judge Richard G. Andrews on 4/8/2022. (nms) |
Apr 8, 2022 | 57 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME to submit a proposed protective order to April 20, 2022 - filed by Sarepta Therapeutics Three, LLC, Sarepta Therapeutics, Inc.. (Fahnestock, Derek) |
Apr 4, 2022 | N/A | Case No Longer Referred to Mediation (0) Docket Text: CASE NO LONGER REFERRED to Chief Magistrate Judge Thynge for the purpose of exploring ADR. Pursuant to the Court's Standing Order No. 2022-2, dated March 14, 2022, "[u]nless otherwise directed by the Court, Magistrate Judges will no longer engage in alternative dispute resolution of patent and securities cases." See also 28 U.S.C. § 652(b). (Taylor, Daniel) |
Mar 31, 2022 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [56] STIPULATION TO EXTEND TIME to submit a proposed protective order to April 8, 2022. Signed by Judge Richard G. Andrews on 3/31/2022. (nms) |
Mar 31, 2022 | 56 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME to submit a proposed protective order to April 8, 2022 - filed by Sarepta Therapeutics Three, LLC, Sarepta Therapeutics, Inc.. (Fahnestock, Derek) |
Mar 28, 2022 | 55 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Plaintiffs REGENXBIO, Inc. and The Trustees of The University of Pennsylvania's First Set of Interrogatories to Defendants Sarepta Therapeutics, Inc. and Sarepta Therapeutics Three, LLC (Nos. 1-5) and Plaintiffs' REGENXBIO, Inc.'s and The Trustees of the University of Pennsylvania's First Set of Requests For Production of Documents and Things to Defendants Sarepta Therapeutics, Inc. and Sarepta Therapeutics Three, LLC (Nos. 1-83) filed by REGENXBIO Inc..(Morrison, Susan) |
Mar 23, 2022 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [54] STIPULATION to Extend Time to submit a proposed protective order to March 31, 2022. Signed by Judge Richard G. Andrews on 3/23/2022. (nms) |
Mar 23, 2022 | 54 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME to submit a proposed protective order to March 31, 2022 - filed by Sarepta Therapeutics Three, LLC, Sarepta Therapeutics, Inc.. (Fahnestock, Derek) |
Mar 9, 2022 | 50 | Notice of Service (5) Docket Text: NOTICE OF SERVICE of Sarepta Therapeutics, Inc. and Sarepta Therapeutics Three, LLC's Initial Disclosures Pursuant to Fed. R. Civ. P. 26(a)(1) and Paragraph 3 of The Default Standard for Discovery - filed by Sarepta Therapeutics Three, LLC, Sarepta Therapeutics, Inc..(Fahnestock, Derek) |
Mar 9, 2022 | 51 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Plaintiff The Trustees of the University of Pennsylvania and REGENXBIO Inc.'s Disclosure of Accused Products filed by REGENXBIO Inc..(Morrison, Susan) |
Mar 9, 2022 | 52 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Plaintiff REGENXBIO Inc.'s Rule 26(a)(1) Initial Disclosures and Plaintiff REGENXBIO Inc.'s Paragraph 3 Disclosures of the Default Standard for Discovery, Including Discovery of Electronically Stored Information filed by REGENXBIO Inc..(Morrison, Susan) |
Mar 9, 2022 | 53 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Plaintiff The Trustees of the University of Pennsylvania's Initial Disclosures Pursuant to Federal Rule of Civil Procedure 26 and Initial ESI Disclosures Pursuant to Paragraph 3 of the Courts Default Standard for Discovery filed by The Trustees of the University of Pennsylvania.(Gorman, John) |
Feb 14, 2022 | 49 | Reply Brief (18) Docket Text: REPLY BRIEF re [40] MOTION for Certification for Interlocutory Appeal filed by Sarepta Therapeutics Three, LLC, Sarepta Therapeutics, Inc.. (Fahnestock, Derek) |
Feb 8, 2022 | 48 | Order (2) Docket Text: ORDER Regarding Production of Settlement and License Agreements. Signed by Judge Richard G. Andrews on 2/8/2022. (nms) |
Feb 7, 2022 | N/A | Case Referred to Mediation (0) Docket Text: CASE REFERRED to Magistrate Judge Mary Pat Thynge for Mediation. Please see Standing Order dated January 20, 2016, regarding disclosure of confidential ADR communications. A link to the standing order is provided here for your convenience at https://www.ded.uscourts.gov/sites/ded/files/forms/StandingOrderforADR-Mediation.pdf (Taylor, Daniel) |
Feb 7, 2022 | N/A | Oral Order (0) Docket Text: ORAL ORDER: This matter has been referred to Chief Magistrate Judge Mary Pat Thynge for ADR. Should any party (or all parties) desire to discuss mediation and its timing, the party(ies) shall contact Judge Thynge and her Law Clerk, Daniel Taylor (daniel_taylor@ded.uscourts.gov), to request that a teleconference be scheduled. Ordered by Judge Mary Pat Thynge on 2/7/2022. (Taylor, Daniel) |
Feb 7, 2022 | 42 | Proposed Order (12) Docket Text: PROPOSED Scheduling Order, by REGENXBIO Inc.. (Morrison, Susan) Modified on 2/7/2022 (nms). |
Feb 7, 2022 | 43 | Letter (1) Docket Text: Letter to The Honorable Richard G. Andrews, from Susan E. Morrison, regarding Rule 16 Conference on February 9, 2022. (Morrison, Susan) Modified on 2/7/2022 (nms). |
Feb 7, 2022 | 44 | Scheduling Order (11) Docket Text: SCHEDULING ORDER: Case referred to the Magistrate Judge for the purpose of exploring ADR. Joinder of Parties due by 1/6/2023. Amended Pleadings due by 1/6/2023. Discovery due by 3/17/2023. Dispositive Motions due by 8/18/2023. Answering Brief due 9/15/2023. Reply Brief due 10/13/2023. Joint Claim Construction Brief due by 11/16/2022. A Markman Hearing is set for 12/20/2022, at 9:00 AM in Courtroom 6A. A Pretrial Conference is set for 1/19/2024, at 9:00 AM in Courtroom 6A. A 5 day Jury Trial is set to start 1/29/2024, at 9:30 AM in Courtroom 6A (see Order for further details). Signed by Judge Richard G. Andrews on 2/7/2022. (nms) |
Feb 7, 2022 | N/A | Oral Order (0) Docket Text: ORAL ORDER: The Rule 16(b) Conference set for 2/9/2022, is CANCELED. Ordered by Judge Richard G. Andrews on 2/7/2022. (nms) |
Feb 7, 2022 | 46 | Proposed Order (2) Docket Text: PROPOSED Order Regarding Production of Settlement and License Agreements, by REGENXBIO Inc., The Trustees of the University of Pennsylvania. (Morrison, Susan) Modified on 2/7/2022 (nms). |
Feb 7, 2022 | 47 | Answering Brief in Opposition (19) Docket Text: ANSWERING BRIEF in Opposition re [40] MOTION for Certification for Interlocutory Appeal filed by REGENXBIO Inc..Reply Brief due date per Local Rules is 2/14/2022. (Morrison, Susan) |
Jan 24, 2022 | 40 | Motion for Miscellaneous Relief (5) Docket Text: MOTION for Certification for Interlocutory Appeal - filed by Sarepta Therapeutics Three, LLC, Sarepta Therapeutics, Inc.. (Blumenfeld, Jack) Modified on 1/25/2022 (nms). |
Jan 24, 2022 | 41 | Opening Brief in Support (22) Docket Text: OPENING BRIEF in Support re [40] MOTION for Certification for Interlocutory Appeal, filed by Sarepta Therapeutics Three, LLC, Sarepta Therapeutics, Inc..Answering Brief/Response due date per Local Rules is 2/7/2022. (Blumenfeld, Jack) Modified on 1/25/2022 (nms). |
Jan 20, 2022 | 39 | Order Setting Scheduling Conference (1) Docket Text: Order Setting Rule 16(b) Telephone Conference: A Scheduling Conference is set for 2/9/2022, at 9:00 AM before Judge Richard G. Andrews (see Order for further details). Signed by Judge Richard G. Andrews on 1/20/2022. (nms) |
Jan 18, 2022 | 38 | Answer to Complaint (11) Docket Text: ANSWER to [1] Complaint, by Sarepta Therapeutics Three, LLC, Sarepta Therapeutics, Inc..(Fahnestock, Derek) Modified on 1/19/2022 (nms). |
Jan 4, 2022 | 36 | Memorandum Opinion (9) Docket Text: MEMORANDUM OPINION. Signed by Judge Richard G. Andrews on 1/4/2022. (nms) |
Jan 4, 2022 | 37 | Order (1) Docket Text: ORDER: Defendants' Motion to Dismiss (D.I. [12]) is DENIED. Signed by Judge Richard G. Andrews on 1/4/2022. (nms) |
Dec 20, 2021 | N/A | Motion Hearing (0) Docket Text: Minute Entry for proceedings held before Judge Richard G. Andrews - Motion Hearing held on 12/20/2021 re [12] MOTION to Dismiss. Local Counsel present for Plaintiffs: S. Morrison, J. Gorman. Local Counsel present for Defendants: J. Blumenfeld. The Court will take the motion under advisement. (Court Reporter Deanna Warner.) (nms) |
Dec 1, 2021 | N/A | Oral Order (0) Docket Text: ORAL ORDER: The hearing regarding the Motion to Dismiss (D.I. [12]) is now rescheduled for 12/20/2021, at 2:00 PM in Courtroom 6A. Ordered by Judge Richard G. Andrews on 12/1/2021. (nms) |
Nov 29, 2021 | N/A | Oral Order (0) Docket Text: ORAL ORDER: Due to a scheduling conflict the hearing scheduled for 12/2/2021, is CANCELED and will be rescheduled for a date to be determined. Ordered by Judge Richard G. Andrews on 11/29/2021. (nms) |
Oct 5, 2021 | N/A | Oral Order (0) Docket Text: ORAL ORDER: A hearing on the Motion to Dismiss (D.I. [12]) is now set for 12/2/2021, at 2:00 PM in Courtroom 6A. Ordered by Judge Richard G. Andrews on 10/5/2021. (nms) |
Sep 15, 2021 | 32 | Letter (1) Docket Text: Letter to The Hon. Richard G. Andrews, from Susan E. Morrison, regarding status of Motion to Dismiss. (Morrison, Susan) Modified on 9/15/2021 (nms). |
May 14, 2021 | N/A | Oral Order (0) Docket Text: ORAL ORDER: The request for leave to file the response at D.I. [30] is GRANTED. Ordered by Judge Richard G. Andrews on 5/14/2021. (nms) |
May 13, 2021 | 30 | Letter (1) Docket Text: Letter to The Honorable Richard G. Andrews, from Jack B. Blumenfeld, regarding response to supplemental authority (D.I. [29]). (Blumenfeld, Jack) Modified on 5/14/2021 (nms). |
May 10, 2021 | 29 | Letter (15) Docket Text: Letter to The Honorable Richard G. Andrews from Susan E. Morrison regarding Supplemental Authority. (Morrison, Susan) |
Apr 7, 2021 | 28 | Letter (1) Docket Text: Letter to The Honorable Richard G. Andrews, from Susan E. Morrison, regarding oral argument. (Morrison, Susan) Modified on 4/7/2021 (nms). |
Dec 16, 2020 | 26 | Request for Oral Argument (1) Docket Text: REQUEST for Oral Argument by REGENXBIO Inc. re [12] MOTION to Dismiss. (Morrison, Susan) |
Dec 16, 2020 | 27 | Request for Oral Argument (4) Docket Text: REQUEST for Oral Argument by Sarepta Therapeutics Three, LLC, Sarepta Therapeutics, Inc. re [12] MOTION to Dismiss. (Fahnestock, Derek) |
Dec 9, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [24] MOTION for Pro Hac Vice Appearance of Attorney Michael J. Flibbert, filed by Sarepta Therapeutics Three, LLC, Sarepta Therapeutics, Inc.. Signed by Judge Richard G. Andrews on 12/9/2020. (nms) |
Dec 9, 2020 | 24 | Motion for Leave to Appear Pro Hac Vice (5) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Michael J. Flibbert - filed by Sarepta Therapeutics Three, LLC, Sarepta Therapeutics, Inc.. (Fahnestock, Derek) |
Dec 9, 2020 | 25 | Reply Brief (17) Docket Text: REPLY BRIEF re [12] MOTION to Dismiss filed by Sarepta Therapeutics Three, LLC, Sarepta Therapeutics, Inc.. (Blumenfeld, Jack) |
Dec 7, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [23] Stipulation and Order(*Reset Briefing Schedule: re [12] MOTION to Dismiss. Reply Brief due 12/9/2020). Signed by Judge Richard G. Andrews on 12/7/2020. (nms) |
Dec 7, 2020 | 23 | Stipulation (2) Docket Text: STIPULATION and Order, by Sarepta Therapeutics Three, LLC, Sarepta Therapeutics, Inc.. (Blumenfeld, Jack) Modified on 12/7/2020 (nms). |
Nov 25, 2020 | 21 | Notice of Appearance (1) Docket Text: NOTICE of Appearance by John V. Gorman on behalf of The Trustees of the University of Pennsylvania (Gorman, John) |
Nov 25, 2020 | 22 | Answering Brief in Opposition (7) Docket Text: ANSWERING BRIEF in Opposition re [12] MOTION to Dismiss filed by The Trustees of the University of Pennsylvania.Reply Brief due date per Local Rules is 12/2/2020. (Gorman, John) |
Nov 20, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [19] STIPULATION and Order to Extend Time to file Opposition and Reply to Motion to Dismiss (D.I. 12) to November 25, 2020 and December 9, 2020. Signed by Judge Richard G. Andrews on 11/20/2020. (nms) |
Nov 20, 2020 | 19 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME to file its Opposition Brief to Sarepta's Motion to Dismiss for Failure to State a Claim (D.I. 12) to November 25, 2020 and Defendants' due date to file Reply Brief is extended to December 9, 2020 - filed by The Trustees of the University of Pennsylvania. (Bomar, Kelsey) |
Nov 20, 2020 | 20 | Answering Brief in Opposition (18) Docket Text: ANSWERING BRIEF in Opposition re [12] MOTION to Dismiss filed by REGENXBIO Inc..Reply Brief due date per Local Rules is 11/27/2020. (Morrison, Susan) |
Nov 19, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [17] MOTION for Pro Hac Vice Appearance of Attorney Eric Kraeutler, Julie S. Goldemberg and Janice H. Logan, filed by The Trustees of the University of Pennsylvania. Signed by Judge Richard G. Andrews on 11/19/2020. (nms) |
Nov 19, 2020 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorneys Eric Kraeutler, Julie S. Goldemberg, Janice H. Logan for The Trustees of the University of Pennsylvania added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (kmd) |
Nov 19, 2020 | 16 | Notice of Appearance (1) Docket Text: NOTICE of Appearance by Kelsey A. Bomar on behalf of The Trustees of the University of Pennsylvania (Bomar, Kelsey) |
Nov 19, 2020 | 17 | Motion for Leave to Appear Pro Hac Vice (4) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Eric Kraeutler, Julie S. Goldemberg and Janice H. Logan - filed by The Trustees of the University of Pennsylvania. (Bomar, Kelsey) |
Nov 19, 2020 | 18 | Notice (Other) (2) Docket Text: NOTICE of Withdrawal of Appearances by REGENXBIO Inc. (Morrison, Susan) |
Nov 18, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [15] STIPULATION and Order (*Reset Briefing Schedule: re [12] MOTION to Dismiss. Answering Brief due 11/20/2020, Reply Brief due 12/7/2020). Signed by Judge Richard G. Andrews on 11/18/2020. (nms) |
Nov 18, 2020 | 15 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION and Order - filed by REGENXBIO Inc., The Trustees of the University of Pennsylvania. (Morrison, Susan) Modified on 11/18/2020 (nms). |
Nov 4, 2020 | 12 | Motion to Dismiss for Failure to State a Claim (3) Docket Text: MOTION to Dismiss - filed by Sarepta Therapeutics Three, LLC, Sarepta Therapeutics, Inc.. (Blumenfeld, Jack) Modified on 11/4/2020 (nms). |
Nov 4, 2020 | 13 | Opening Brief in Support (Main Document) (22) Docket Text: OPENING BRIEF in Support re [12] MOTION to Dismiss, filed by Sarepta Therapeutics Three, LLC, Sarepta Therapeutics, Inc..Answering Brief/Response due date per Local Rules is 11/18/2020. (Attachments: # (1) Exhibits 1-2)(Blumenfeld, Jack) Modified on 11/4/2020 (nms). |
Nov 4, 2020 | 13 | Opening Brief in Support (Exhibits 1-2) (30) Docket Text: OPENING BRIEF in Support re [12] MOTION to Dismiss, filed by Sarepta Therapeutics Three, LLC, Sarepta Therapeutics, Inc..Answering Brief/Response due date per Local Rules is 11/18/2020. (Attachments: # (1) Exhibits 1-2)(Blumenfeld, Jack) Modified on 11/4/2020 (nms). |
Nov 4, 2020 | 14 | Disclosure Statement (3) Docket Text: Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Sarepta Therapeutics Three, LLC, Sarepta Therapeutics, Inc.. (Blumenfeld, Jack) |
Oct 1, 2020 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Kurt L. Glitzenstein for REGENXBIO Inc. and The Trustees of the University of Pennsylvania added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (kmd) |
Sep 30, 2020 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Reassigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. (rjb) |
Sep 30, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [8] MOTION for Pro Hac Vice Appearance of Attorney Charles E. Lipsey and William B. Raich ofFinnegan, Henderson, Farabow, Garrett & Dunner, LLP, filed by Sarepta Therapeutics Three, LLC, Sarepta Therapeutics, Inc.. Signed by Judge Richard G. Andrews on 9/30/2020. (nms) |
Sep 30, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [9] MOTION for Pro Hac Vice Appearance of Attorney Andrew M. Berdon, Robert B. Wilson and James E. Baker of Quinn Emanuel Urquhart & Sullivan LLP, filed by Sarepta Therapeutics Three, LLC, Sarepta Therapeutics, Inc.. Signed by Judge Richard G. Andrews on 9/30/2020. (nms) |
Sep 30, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [11] MOTION for Pro Hac Vice Appearance of Attorney Kurt Glitzenstein, Brian Coggio and Jeremy T. Saks, filed by The Trustees of the University of Pennsylvania, REGENXBIO Inc.. Signed by Judge Richard G. Andrews on 9/30/2020. (nms) |
Sep 30, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [10] STIPULATION and Order to Extend Time to respond to the Complaint to November 6, 2020 (*Reset Answer Deadlines: Sarepta Therapeutics Three, LLC answer due 11/7/2020; Sarepta Therapeutics, Inc. answer due 11/7/2020). Signed by Judge Richard G. Andrews on 9/30/2020. (nms) |
Sep 24, 2020 | 11 | Motion for Leave to Appear Pro Hac Vice (5) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Kurt Glitzenstein, Brian Coggio and Jeremy T. Saks - filed by REGENXBIO Inc., The Trustees of the University of Pennsylvania. (Morrison, Susan) |
Sep 23, 2020 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Assigned to Judge Leonard P. Stark. Please include the initials of the Judge (LPS) after the case number on all documents filed. (rjb) |
Sep 22, 2020 | 8 | Motion for Leave to Appear Pro Hac Vice (5) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Charles E. Lipsey and William B. Raich of FINNEGAN, HENDERSON, FARABOW, GARRETT & DUNNER, LLP - filed by Sarepta Therapeutics Three, LLC, Sarepta Therapeutics, Inc.. (Blumenfeld, Jack) |
Sep 22, 2020 | 9 | Motion for Leave to Appear Pro Hac Vice (6) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Andrew M. Berdon, Robert B. Wilson and James E. Baker of QUINN EMANUEL URQUHART & SULLIVAN LLP - filed by Sarepta Therapeutics Three, LLC, Sarepta Therapeutics, Inc.. (Blumenfeld, Jack) |
Sep 22, 2020 | 10 | Stipulation to EXTEND Time (1) Docket Text: STIPULATION TO EXTEND TIME for defendants to respond to the Complaint to November 6, 2020 - filed by Sarepta Therapeutics Three, LLC, Sarepta Therapeutics, Inc.. (Blumenfeld, Jack) |
Sep 17, 2020 | 7 | Summons Returned Executed (3) Docket Text: SUMMONS Returned Executed by REGENXBIO Inc., The Trustees of the University of Pennsylvania. Sarepta Therapeutics Three, LLC served on 9/16/2020, answer due 10/7/2020; Sarepta Therapeutics, Inc. served on 9/16/2020, answer due 10/7/2020. (Morrison, Susan) |
Sep 15, 2020 | 1 | Complaint* (1) |
Sep 15, 2020 | 1 | Complaint (Main Document) (11) Docket Text: COMPLAINT FOR PATENT INFRINGEMENT - filed with Jury Demand against Sarepta Therapeutics Three, LLC, Sarepta Therapeutics, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number ADEDC-3200426.) - filed by REGENXBIO Inc., The Trustees of the University of Pennsylvania. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G, # (8) Exhibit H, # (9) Exhibit I, # (10) Exhibit J, # (11) Exhibit K, # (12) Exhibit L, # (13) Civil Cover Sheet)(mal) |
Sep 15, 2020 | 1 | Complaint (Exhibit A) (30) Docket Text: COMPLAINT FOR PATENT INFRINGEMENT - filed with Jury Demand against Sarepta Therapeutics Three, LLC, Sarepta Therapeutics, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number ADEDC-3200426.) - filed by REGENXBIO Inc., The Trustees of the University of Pennsylvania. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G, # (8) Exhibit H, # (9) Exhibit I, # (10) Exhibit J, # (11) Exhibit K, # (12) Exhibit L, # (13) Civil Cover Sheet)(mal) |
Sep 15, 2020 | 1 | Complaint (Exhibit B) (26) Docket Text: COMPLAINT FOR PATENT INFRINGEMENT - filed with Jury Demand against Sarepta Therapeutics Three, LLC, Sarepta Therapeutics, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number ADEDC-3200426.) - filed by REGENXBIO Inc., The Trustees of the University of Pennsylvania. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G, # (8) Exhibit H, # (9) Exhibit I, # (10) Exhibit J, # (11) Exhibit K, # (12) Exhibit L, # (13) Civil Cover Sheet)(mal) |
Sep 15, 2020 | 1 | Complaint (Exhibit C) (30) Docket Text: COMPLAINT FOR PATENT INFRINGEMENT - filed with Jury Demand against Sarepta Therapeutics Three, LLC, Sarepta Therapeutics, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number ADEDC-3200426.) - filed by REGENXBIO Inc., The Trustees of the University of Pennsylvania. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G, # (8) Exhibit H, # (9) Exhibit I, # (10) Exhibit J, # (11) Exhibit K, # (12) Exhibit L, # (13) Civil Cover Sheet)(mal) |
Sep 15, 2020 | 1 | Complaint (Exhibit D) (15) Docket Text: COMPLAINT FOR PATENT INFRINGEMENT - filed with Jury Demand against Sarepta Therapeutics Three, LLC, Sarepta Therapeutics, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number ADEDC-3200426.) - filed by REGENXBIO Inc., The Trustees of the University of Pennsylvania. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G, # (8) Exhibit H, # (9) Exhibit I, # (10) Exhibit J, # (11) Exhibit K, # (12) Exhibit L, # (13) Civil Cover Sheet)(mal) |
Sep 15, 2020 | 1 | Complaint (Exhibit E) (4) Docket Text: COMPLAINT FOR PATENT INFRINGEMENT - filed with Jury Demand against Sarepta Therapeutics Three, LLC, Sarepta Therapeutics, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number ADEDC-3200426.) - filed by REGENXBIO Inc., The Trustees of the University of Pennsylvania. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G, # (8) Exhibit H, # (9) Exhibit I, # (10) Exhibit J, # (11) Exhibit K, # (12) Exhibit L, # (13) Civil Cover Sheet)(mal) |
Sep 15, 2020 | 1 | Complaint (Exhibit F) (4) Docket Text: COMPLAINT FOR PATENT INFRINGEMENT - filed with Jury Demand against Sarepta Therapeutics Three, LLC, Sarepta Therapeutics, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number ADEDC-3200426.) - filed by REGENXBIO Inc., The Trustees of the University of Pennsylvania. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G, # (8) Exhibit H, # (9) Exhibit I, # (10) Exhibit J, # (11) Exhibit K, # (12) Exhibit L, # (13) Civil Cover Sheet)(mal) |
Sep 15, 2020 | 1 | Complaint (Exhibit G) (6) Docket Text: COMPLAINT FOR PATENT INFRINGEMENT - filed with Jury Demand against Sarepta Therapeutics Three, LLC, Sarepta Therapeutics, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number ADEDC-3200426.) - filed by REGENXBIO Inc., The Trustees of the University of Pennsylvania. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G, # (8) Exhibit H, # (9) Exhibit I, # (10) Exhibit J, # (11) Exhibit K, # (12) Exhibit L, # (13) Civil Cover Sheet)(mal) |
Sep 15, 2020 | 1 | Complaint (Exhibit H) (30) Docket Text: COMPLAINT FOR PATENT INFRINGEMENT - filed with Jury Demand against Sarepta Therapeutics Three, LLC, Sarepta Therapeutics, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number ADEDC-3200426.) - filed by REGENXBIO Inc., The Trustees of the University of Pennsylvania. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G, # (8) Exhibit H, # (9) Exhibit I, # (10) Exhibit J, # (11) Exhibit K, # (12) Exhibit L, # (13) Civil Cover Sheet)(mal) |
Sep 15, 2020 | 1 | Complaint (Exhibit I) (5) Docket Text: COMPLAINT FOR PATENT INFRINGEMENT - filed with Jury Demand against Sarepta Therapeutics Three, LLC, Sarepta Therapeutics, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number ADEDC-3200426.) - filed by REGENXBIO Inc., The Trustees of the University of Pennsylvania. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G, # (8) Exhibit H, # (9) Exhibit I, # (10) Exhibit J, # (11) Exhibit K, # (12) Exhibit L, # (13) Civil Cover Sheet)(mal) |
Sep 15, 2020 | 1 | Complaint (Exhibit J) (30) Docket Text: COMPLAINT FOR PATENT INFRINGEMENT - filed with Jury Demand against Sarepta Therapeutics Three, LLC, Sarepta Therapeutics, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number ADEDC-3200426.) - filed by REGENXBIO Inc., The Trustees of the University of Pennsylvania. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G, # (8) Exhibit H, # (9) Exhibit I, # (10) Exhibit J, # (11) Exhibit K, # (12) Exhibit L, # (13) Civil Cover Sheet)(mal) |
Sep 15, 2020 | 1 | Complaint (Exhibit K) (24) Docket Text: COMPLAINT FOR PATENT INFRINGEMENT - filed with Jury Demand against Sarepta Therapeutics Three, LLC, Sarepta Therapeutics, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number ADEDC-3200426.) - filed by REGENXBIO Inc., The Trustees of the University of Pennsylvania. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G, # (8) Exhibit H, # (9) Exhibit I, # (10) Exhibit J, # (11) Exhibit K, # (12) Exhibit L, # (13) Civil Cover Sheet)(mal) |
Sep 15, 2020 | 1 | Complaint (Exhibit L) (2) Docket Text: COMPLAINT FOR PATENT INFRINGEMENT - filed with Jury Demand against Sarepta Therapeutics Three, LLC, Sarepta Therapeutics, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number ADEDC-3200426.) - filed by REGENXBIO Inc., The Trustees of the University of Pennsylvania. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G, # (8) Exhibit H, # (9) Exhibit I, # (10) Exhibit J, # (11) Exhibit K, # (12) Exhibit L, # (13) Civil Cover Sheet)(mal) |
Sep 15, 2020 | 1 | Complaint (Civil Cover Sheet) (1) Docket Text: COMPLAINT FOR PATENT INFRINGEMENT - filed with Jury Demand against Sarepta Therapeutics Three, LLC, Sarepta Therapeutics, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number ADEDC-3200426.) - filed by REGENXBIO Inc., The Trustees of the University of Pennsylvania. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G, # (8) Exhibit H, # (9) Exhibit I, # (10) Exhibit J, # (11) Exhibit K, # (12) Exhibit L, # (13) Civil Cover Sheet)(mal) |
Sep 15, 2020 | 2 | Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (mal) |
Sep 15, 2020 | 3 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 10,526,617 B2. (mal) |
Sep 15, 2020 | 4 | Disclosure Statement (1) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Other Affiliate BlackRock, Inc. for REGENXBIO Inc. filed by REGENXBIO Inc.. (mal) |
Sep 15, 2020 | 5 | Disclosure Statement (1) Docket Text: Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by The Trustees of the University of Pennsylvania. (mal) |
Sep 15, 2020 | 6 | Summons Issued - Electronic (2) Docket Text: Summonses Issued (please complete the top portion of the form and print out for use/service). (mal) |